Biotechnology
New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials
Pharmaceutical clinical industry report highlights factors impacting volume, cost and duration of Phase II trials LONDON, Nov. 24, 2020 /PRNewswire/ -- Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced t...
2020-11-24 16:05
Sunway University Researcher Looks into Genomes and Allergies
KUALA LUMPUR, Malaysia, Nov. 24, 2020 /PRNewswire/ -- Dust mites, common in most human habitats are also one of the most common causes of allergies. Dr Kavita Reginald, Senior Lecturer from the Department of Biological Sciences at Sunway University has made it her interest to study these microscop...
2020-11-24 09:00
473
Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19
AUCKLAND, New Zealand, Nov. 24, 2020 /PRNewswire/ -- Koru Lifescience, drug discovery, and advanced formulation research laboratory inAuckland, New Zealand , has identified several known drug compounds of value in their study for a treatment of Covid-19. The study reports shall be published after ...
2020-11-24 04:35
289
3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212
SHENYANG, China, Nov. 23, 2020 /PRNewswire/ -- Chinese leading biopharmaceutical company, 3SBio Inc.(01530.HK, the "Company"), announced today that Selecta Biosciences, Inc. (Nasdaq: SELB), the Company's partner, has commenced the phase III clinical program of a combination therapy involving SEL...
2020-11-23 21:28
2026
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowle...
2020-11-23 09:00
745
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange
HONG KONG, Nov. 20, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer medicines, today announced that the company was officially listed and it's shares commenced trading on the Main Board...
2020-11-20 21:09
7071
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease
RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy The Phase 3 study is expected to recruit up to 125 patients across approximately 40 U.S. clinical sites RHB-...
2020-11-20 21:00
4147
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou
HANGZHOU, China, Nov. 20, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced its biologics integrated innovation center has been in operation inHangzhou, Zhejiang province, China. From process deve...
2020-11-20 16:30
424
RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease
FDA clears IND application for Phase 2/3 study with RedHill's second novel COVID-19 candidate, RHB-107 (upamostat), an orally administered novel serine protease inhibitor, with demonstrated antiviral and potential tissue-protective effects The Phase 2/3 study is designed to evaluate outpatient-b...
2020-11-20 07:00
1802
Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology
Summarizes ciraparantag's expected mechanism of action, pharmacokinetic, and pharmacodynamic characteristics and its proof of concept as an anticoagulant reversal agent LUXEMBOURG and ZUG, Switzerland, Nov. 20, 2020 /PRNewswire/ -- Covis Group S.à r.l. ("Covis") today announced that data demonst...
2020-11-20 01:26
959
RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib
Pre-scheduled independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia Enrollment in the 270-patient global Phase 2/3 COVID-19 study with opaganib is more than 50% complete ...
2020-11-19 20:21
3279
With Elekta Studio, Elekta brings complete image-guided brachytherapy workflow to a single room
VEENENDAAL, The Netherlands, Nov. 19, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today introduced Elekta Studio with its launch of the ImagingRing, an advanced interventional CT system that revolves around the patient and enables clinicians to conduct the entire brachytherapy workflow - including ap...
2020-11-19 15:16
3280
Mibelle Biochemistry's Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market Lauded by Frost & Sullivan
The company's active ingredient product lines meet consumer expectations of quality, performance, and sustainability LONDON, Nov. 18, 2020 /PRNewswire/ -- Based on its recent analysis of the global personal care active ingredients market, Frost & Sullivan recognizes Mibelle AG Biochemistry with t...
2020-11-18 23:40
771
Deep Longevity Launches The First Longevity Medicine Course For Physicians
HONG KONG, Nov. 18, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging...
2020-11-18 23:00
8000
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2021 Financial Results
HONG KONG, Nov. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...
2020-11-18 20:00
5996
HistoIndex's AI-Based Platform Demonstrates Zonal Quantification and Histological Characterization of Fibrosis Improvements in Patients With Nonalcoholic Steatohepatitis (NASH)
SINGAPORE, Nov. 18, 2020 /PRNewswire/ -- HistoIndex
2020-11-18 20:00
695
Chinese biotech company releases rapid COVID-19 antigen test with easy-to-use nasal swab
BINHAI, China, Nov. 18, 2020 /PRNewswire/ -- JOYSBIO Biotechnology Co., Ltd. announced today that they have introduced a new rapid COVID-19 antigen test kit available to medical facilities around the world as well as direct-to-consumer for at-home testing depending on local legislation. The kit ...
2020-11-18 16:38
439
Kazia Presents Further Paxalisib Data At Sno, Confirming Earlier Positive Safety And Efficacy Signals In Glioblastoma
SYDNEY, Nov. 18, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a summary of new paxalisib data presented at the Society for Neuro-Oncology (SNO) Annual Meeting, which is being held virtually from...
2020-11-18 07:39
1921
Foxx Life Sciences Announces Opening of New Asia Headquarters in India
SALEM, New Hampshire, Nov. 17, 2020 /PRNewswire/ -- Foxx Life Sciences announced on Tuesday that it will open the new internationalAsia headquarters in Medchal,Hyderabad, India. The latest expansion comes with strong growth and performance inAsia and the continued expansion of Biopharmaceutical ...
2020-11-17 21:00
551
Visiopharm's AI-Powered Image Analysis Software Selected to Analyze the Largest Collection of Human Pathology Specimens in the World
DENVER and HOERSHOLM, Denmark, Nov. 17, 2020 /PRNewswire/ -- Visiopharm, the leader in artificial intelligence-driven image analysis, tissue mining, and precision pathology, has been selected by the Joint Pathology Center (JPC), the premier pathology reference center forthe United States federal ...
2020-11-17 16:17
488
Week's Top Stories
Most Reposted
SiteMinder partners with AsiaPay to simplify hotel customer payments across Asia
[Picked up by 125 media titles]
2020-11-18 10:07Xinhua Silk Road: AI empowers China-ASEAN cooperation, helping tap into market opportunities
[Picked up by 112 media titles]
2020-11-17 11:24
UNESCO to Host Online Debate on Empowering Women in the Digital Sphere on 25 November 2020
[Picked up by 111 media titles]
2020-11-18 12:51
Sephora Singapore partners with Atome in offering buy now, pay later payments
[Picked up by 111 media titles]
2020-11-18 09:00Xinhua Silk Road: Liuyang, China to invite public bidding for Liuyang River cultural tourism project on Nov. 26
[Picked up by 108 media titles]
2020-11-18 16:41
Most Read
CRRC's 400km/h Cross-border Interconnection High-speed Train Rolls Off Assembly Line at CRRC Changchun
2020-11-18 16:30
18903
The Sanchaya Launches Island Oasis Getaway with Private Jet
2020-11-19 15:15
16885
Expanded Market Share to 20.8%, Grew Volume 51.2% to 4.6 Billion Parcels
2020-11-19 06:00
8374
Deep Longevity Launches The First Longevity Medicine Course For Physicians
2020-11-18 23:00
7996